4 ms·
It keeps annoying me that nearly everyone (including Richard Posner [0] and notch [1]) says that 'medicine makes for the best case for patents'. I'm not convin
by dnautics 12y ago
It keeps annoying me that nearly everyone (including Richard Posner [0] and notch [1]) says that 'medicine makes for the best case for patents'. I'm not convinced that patents are necessary for pharmaceuticals, and I'm trying to prove that's the case [2].
[0] http://www.theatlantic.com/business/archive/2012/07/why-there-are-too-many-patents-in-america/259725/ http://www.theatlantic.com/business/archive/2012/07/why-ther...
[1] http://notch.tumblr.com/post/27751395263/on-patents http://notch.tumblr.com/post/27751395263/on-patents
[2] http://indysci.org/projectmarilyn http://indysci.org/projectmarilyn
- pessimizer 12y agoI don't know if you're familiar with Dean Baker: "Patent monopolies are one mechanism to provide an incentive for innovation, however they are a tremendously inefficient mechanism." http://www.cepr.net/index.php/blogs/beat-the-press/health-care-costs-dont-blame-the-free-market http://www.cepr.net/index.php/blogs/beat-the-press/health-ca... http://www.cepr.net/index.php/Publications/Reports/financing-drug-research-what-are-the-issues http://www.cepr.net/index.php/Publications/Reports/financing...
- dnautics 12y agothank you for those links. Incidentally Drew Curtis also outlines the dichotomy in policy pressures really well. http://www.ted.com/talks/drew_curtis_how_i_beat_a_patent_troll http://www.ted.com/talks/drew_curtis_how_i_beat_a_patent_tro... I'm surprised that the first link of yours doesn't show the fact that Pharma companies make upwards of 10-16% margin which is high for the healthcare sector, versus Generics companies which make ~5%, in line with "companies in general"; and insurance companies which pre-ACA were making negative-~2% margins. It's hard not to believe that the ACA was just a bailout for insurance companies, in exchange for mild vilification.
- pessimizer 12y ago>I'm surprised that the first link of yours doesn't show the fact https://encrypted.google.com/search?hl=en&q=medical%20patent%20site%3Acepr.net https://encrypted.google.com/search?hl=en&q=medical%20patent... Dean Baker has written a lot on patents in medicine, and in other fields as well. It would probably be interesting for you.
- lobo_tuerto 12y agonotch didn't mention that in the link you provide. He said: "but I do understand why some people thing(sic) patents are good in these areas"
- dnautics 12y agoI didn't mean for that to be an exact quote, and certainly I think it's likely that notch disagrees, but he is saying that the most convincing case for patents is in medicine.
- poopchute 12y agoWell lets quote the whole paragraph, because I think you are misreading. "I will say that there are areas which are very costly to research, but where the benefits for mankind long term are very positive. I would personally prefer it to have those be government funded (like with CERN or NASA) and patent free as opposed to what’s happening with medicine, but I do understand why some people thing patents are good in these areas." No where there does he say what you are claiming. In fact, he specifically says that he thinks there should be no patents in medicine.
- dnautics 12y agoI think it's likely that notch disagrees = he thinks there should be no patents in medicine. he is saying that the most convincing case for patents is in medicine = I do understand why some people thing patents are good in these areas.
- lobo_tuerto 12y agoNo, he is not saying that, stop trying to twist his words to whatever you want to believe.
- anigbrowl 12y agoThat's a worthy venture, but if your project needs $5 billion (or some other large sum) and takes 10 years, are you going to be able to get people to donate steadily for so long? Giving it away is laudable for sure, but most people consider patents the tradeoff to attract the huge sums of capital over a medium investment term that are required for drug development.
- dnautics 12y agoThe development of an oncologic (from preclinical through clinical) typically costs more like 10-20 million dollars. I'm not sure where you got 5 billion from. Now, pharma companies inflate the cost of a single drug by creatively rolling in a lot of failures as the 'cost of getting there', sometimes warranted, often maybe not so much. As it is big pharma spends more money on advertising than R&D anyways. Generics manufacturers, incidentally, do just fine, and I can imagine a more sustainable model of pharmacological research where a generics builds up an R&D war chest and periodically discharges it on new research. The hard part is the political intractability of getting big pharma to let go of 20% margins and settle for 5% margins. Edit: error, 10mm only for preclinical, not both.
- sliverstorm 12y agoAt 5% margins, I would think there are a lot of better places to invest your money.
- jonlucc 12y ago10-20 million is nowhere close. A single moderate size monkey study costs around $900,000 at a CRO (because most pharma companies don't have their own NHP facilities). This paper [1] places it between $500 million and $2 billion, but it apparently uses a source of self-reported data from the industry. Phase 3 studies are often in the hundreds of millions of dollars range, because they have to basically pay for a thousand or more subjects to have Rx-quality drug and intermittent medical care for several years. [1] http://content.healthaffairs.org/content/25/2/420 http://content.healthaffairs.org/content/25/2/420
- chris_va 12y agoDo you think crowdsourcing $300B/year is going to be (A) feasible, and (B) more capital efficient than having a bunch of experts attempting to extract maximum value from their revenue stream? I think crowdsourcing can certainly play a role (and in effect the NIH is a big crowdsourced entity, and accounts for a huge amount of pharmaceutical research), however it does not seem like a full replacement.